ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.385
0.39%
Bitcoin
57,800.01
0.07%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
04/12/20221:24PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
04/06/202210:52AMDow Jones NewsGlaxoSmithKline Study Shows Covid-19 Patients Over 50 at Greater Risk for ShinglesNYSE:GSKGSK plc
04/06/202210:00AMBusiness WireNew Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+NYSE:GSKGSK plc
04/01/202211:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/28/20229:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/25/20224:57PMDow Jones NewsFDA Limits Use of Sotrovimab to Treat Covid-19 Due to BA.2 Omicron Subordinated-variantNYSE:GSKGSK plc
03/25/20224:04PMGlobeNewswire Inc.US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 SubvariantNYSE:GSKGSK plc
03/24/20223:54PMDow Jones NewsFDA Approves Label Update for Long-Acting HIV Treatment CabenuvaNYSE:GSKGSK plc
03/24/202212:08PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/24/202210:53AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/15/20221:56PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/15/202210:58AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/15/20226:47AMDow Jones NewsGlaxoSmithKline Appoints Directors to Board of New Consumer-Health Company HaleonNYSE:GSKGSK plc
03/08/20222:07PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/08/20221:10PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:GSKGSK plc
03/07/20229:09AMBusiness WireAlacer Corp. Launches New Eco-Conscious Toothpaste Brand Natean®NYSE:GSKGSK plc
03/01/202211:24AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/01/202210:44AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/01/20227:35AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/01/20226:37AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
03/01/20222:42AMDow Jones NewsGlaxoSmithKline Says Daprodustat Drug Gets EU Marketing AuthorizationNYSE:GSKGSK plc
02/28/202210:18AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
02/28/202210:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
02/28/20226:55AMDow Jones NewsGlaxoSmithKline to Spin Off Haleon Consumer Business in July; Targets 4%-6% Sales GrowthNYSE:GSKGSK plc
02/28/20222:45AMDow Jones NewsGlaxoSmithKline Stops Enrollment, Vaccination in RSV Maternal Vaccine TrialsNYSE:GSKGSK plc
02/24/202211:05AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
02/24/202210:59AMDow Jones NewsGlaxoSmithKline Gets Covifenz Covid-19 Vaccine Approval in CanadaNYSE:GSKGSK plc
02/24/20225:44AMDow Jones NewsGlaxoSmithKline's Covid-19 Treatment Use Limited by FDANYSE:GSKGSK plc
02/23/202211:29AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
02/23/20226:09AMDow Jones NewsSanofi, GSK to Seek Approval for Covid-19 Vaccine After Positive Trial ResultsNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
AXXA
Exxe (PK)
AMEX
SPY
SPDR S&P 500
NASDAQ
AMRN
Amarin
USOTC
RNVA
Rennova Health (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved